VEGFR / Flk Antibodies

Santa Cruz Biotechnology features a diverse variety of VEGFR / Flk monoclonal antibodies for research in vascular biology and angiogenesis. VEGFR / Flk Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Vascular Endothelial Growth Factor Receptor (VEGFR), also known as Flk, plays a critical role in mediating the effects of VEGF, which is essential for blood vessel formation and maintenance. VEGFR signaling is vital for normal physiological processes, including wound healing and tissue repair. In pathological conditions such as cancer, aberrant angiogenesis can lead to tumor growth and metastasis. Understanding VEGFR signaling pathways and interactions opens new possibilities for targeted therapies in oncology and other diseases. Researchers can explore VEGFR's role in both normal and pathological angiogenesis using specific detection methods. Advanced imaging techniques and protein analysis methods reveal detailed insights into VEGFR function and regulation. Santa Cruz Biotechnology monoclonal antibodies for VEGFR / Flk support breakthrough discoveries in vascular biology research, advancing our understanding of disease mechanisms and potential therapeutic approaches.